{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:29:13Z","timestamp":1793071753240,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH107435"],"award-info":[{"award-number":["MH107435"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AA026186"],"award-info":[{"award-number":["AA026186"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.biopsych.2020.01.015","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T08:59:59Z","timestamp":1584435599000},"page":"520-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics"],"prefix":"10.1016","volume":"88","author":[{"given":"Gaurav","family":"Bedse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew N.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8052-520X","authenticated-orcid":false,"given":"Sachin","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2020.01.015_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw1391","article-title":"The origins of cannabis smoking: Chemical residue evidence from the first millennium BCE in the Pamirs","volume":"5","author":"Ren","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.biopsych.2020.01.015_bib2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2146\/ajhp140523","article-title":"Use and effects of cannabinoids in military veterans with posttraumatic stress disorder","volume":"72","author":"Betthauser","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.biopsych.2020.01.015_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jts.20243","article-title":"Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users","volume":"20","author":"Bonn-Miller","year":"2007","journal-title":"J\u00a0Trauma Stress"},{"key":"10.1016\/j.biopsych.2020.01.015_bib4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.7326\/M18-0810","article-title":"Risks and benefits of marijuana use: a national survey of U.S. adults","volume":"169","author":"Keyhani","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.biopsych.2020.01.015_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.addbeh.2017.06.007","article-title":"Daily-level associations between PTSD and cannabis use among young sexual minority women","volume":"74","author":"Dworkin","year":"2017","journal-title":"Addict Behav"},{"key":"10.1016\/j.biopsych.2020.01.015_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.vh.2016.09.006","article-title":"The endocannabinoid system and anxiety","volume":"103","author":"Lisboa","year":"2017","journal-title":"Vitam Horm"},{"key":"10.1016\/j.biopsych.2020.01.015_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2017.162","article-title":"Integrating endocannabinoid signaling and cannabinoids into the biology and treatment of posttraumatic stress disorder","volume":"43","author":"Hill","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","volume":"76","author":"Patel","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2020.01.015_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tips.2013.08.008","article-title":"Amygdala FAAH and anandamide: Mediating protection and recovery from stress","volume":"34","author":"Gunduz-Cinar","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-20825-1_3","article-title":"Distribution of the endocannabinoid system in the central nervous system","volume":"231","author":"Hu","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejphar.2018.07.039","article-title":"Endocannabinoid system, stress and HPA axis","volume":"834","author":"Micale","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2020.01.015_bib14","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.biopsych.2020.01.015_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2215-0366(18)30427-9","article-title":"Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: A double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial","volume":"6","author":"D\u2019Souza","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biopsych.2019.07.034","article-title":"Elevated anandamide, enhanced recall of fear extinction, and attenuated stress responses following inhibition of fatty acid amide hydrolase (FAAH): A randomized, controlled experimental medicine trial","volume":"87","author":"Mayo","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib17","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1021\/acs.jmedchem.8b01405","article-title":"Activity-based protein profiling delivers selective drug candidate ABX-1431, a monoacylglycerol lipase inhibitor, to control lipid metabolism in neurological disorders","volume":"61","author":"Jiang","year":"2018","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2020.01.015_bib18","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1021\/acs.jmedchem.8b00951","article-title":"Identification of ABX-1431, a selective inhibitor of monoacylglycerol lipase and clinical candidate for treatment of neurological disorders","volume":"61","author":"Cisar","year":"2018","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2020.01.015_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biopsych.2020.01.015_bib21","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1124\/mol.107.037796","article-title":"A\u00a0key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization","volume":"72","author":"Jung","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib22","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.celrep.2014.11.001","article-title":"Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation","volume":"9","author":"Shonesy","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.biopsych.2020.01.015_bib23","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1523\/JNEUROSCI.5693-09.2010","article-title":"Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice","volume":"30","author":"Gao","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib24","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A\u00a0comprehensive profile\u00a0of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem Biol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1748-1716.2011.02280.x","article-title":"The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors","volume":"204","author":"Savinainen","year":"2012","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.biopsych.2020.01.015_bib26","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1021\/acschemneuro.7b00499","article-title":"Detection of cyclooxygenase-2-derived oxygenation products of the endogenous cannabinoid 2-arachidonoylglycerol in mouse brain","volume":"9","author":"Morgan","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib27","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1073\/pnas.1217121110","article-title":"ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC","volume":"110","author":"Blankman","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2020.01.015_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajhg.2010.08.002","article-title":"Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism","volume":"87","author":"Fiskerstrand","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2020.01.015_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-neuro-062111-150420","article-title":"Multiple functions of endocannabinoid signaling in the brain","volume":"35","author":"Katona","year":"2012","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2014.03.017","article-title":"Endocannabinoid-mediated retrograde modulation of synaptic transmission","volume":"29","author":"Ohno-Shosaku","year":"2014","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2020.01.015_bib32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2008.01.029","article-title":"Endocannabinoids mediate neuron-astrocyte communication","volume":"57","author":"Navarrete","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2020.01.015_bib33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.neuron.2014.01.012","article-title":"Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses","volume":"81","author":"Ramikie","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2020.01.015_bib34","doi-asserted-by":"crossref","first-page":"20130599","DOI":"10.1098\/rstb.2013.0599","article-title":"Astrocytes in endocannabinoid signalling","volume":"369","author":"Navarrete","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib35","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/nn1521","article-title":"Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus","volume":"8","author":"Makara","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1124\/jpet.109.158162","article-title":"Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) enhances retrograde endocannabinoid signaling","volume":"331","author":"Pan","year":"2009","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2020.01.015_bib37","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1476-5381.2011.01486.x","article-title":"COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation","volume":"164","author":"Straiker","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib38","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.chembiol.2009.05.009","article-title":"Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism","volume":"16","author":"Long","year":"2009","journal-title":"Chem Biol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib39","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2020.01.015_bib40","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1073\/pnas.0914661107","article-title":"Endogenous cannabinoid signaling is essential for stress adaptation","volume":"107","author":"Hill","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2020.01.015_bib41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.biopsych.2017.03.002","article-title":"Functional redundancy between canonical endocannabinoid signaling systems in the modulation of anxiety","volume":"82","author":"Bedse","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib42","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1038\/tp.2014.53","article-title":"Central anandamide deficiency predicts stress-induced anxiety: Behavioral reversal through endocannabinoid augmentation","volume":"4","author":"Bluett","year":"2014","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib43","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1038\/npp.2009.114","article-title":"Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis","volume":"34","author":"Hill","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib44","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1460-9568.2005.03916.x","article-title":"Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling","volume":"21","author":"Patel","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib45","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1523\/JNEUROSCI.0496-11.2011","article-title":"Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response","volume":"31","author":"Hill","year":"2011","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yfrne.2017.07.005","article-title":"Endocannabinoids: effectors of glucocorticoid signaling","volume":"47","author":"Balsevich","year":"2017","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib47","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1523\/JNEUROSCI.2279-15.2016","article-title":"Acute stress suppresses synaptic inhibition and increases anxiety via endocannabinoid release in the basolateral amygdala","volume":"36","author":"Di","year":"2016","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib48","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1210\/en.2005-0610","article-title":"Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons","volume":"146","author":"Di","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib49","doi-asserted-by":"crossref","first-page":"11188","DOI":"10.1523\/JNEUROSCI.1046-10.2010","article-title":"Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus","volume":"30","author":"Wamsteeker","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0269881111409606","article-title":"Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation","volume":"26","author":"Wang","year":"2012","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.npp.1300601","article-title":"Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress","volume":"30","author":"Hill","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib52","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.neuron.2015.02.015","article-title":"Chronic stress induces anxiety via an amygdalar intracellular cascade that impairs endocannabinoid signaling","volume":"85","author":"Qin","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2020.01.015_bib53","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/npp.2014.24","article-title":"Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling","volume":"39","author":"Zhong","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41398-018-0141-7","article-title":"Therapeutic endocannabinoid augmentation for mood and anxiety disorders: Comparative profiling of FAAH, MAGL and dual inhibitors","volume":"8","author":"Bedse","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib55","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.biopsych.2015.03.033","article-title":"Anxiety, stress, and fear response in mice with reduced endocannabinoid levels","volume":"79","author":"Jenniches","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib56","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/gbb.12045","article-title":"CB1 receptor signaling regulates social anxiety and memory","volume":"12","author":"Litvin","year":"2013","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.biopsych.2020.01.015_bib57","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.euroneuro.2015.04.026","article-title":"Evidence against a critical role of CB1 receptors in adaptation of the hypothalamic-pituitary-adrenal axis and other consequences of daily repeated stress","volume":"25","author":"Rabasa","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib58","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/cercor\/bhq280","article-title":"Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress","volume":"21","author":"Hill","year":"2011","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2020.01.015_bib59","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nbd.2010.03.020","article-title":"Depression-like phenotype following chronic CB1 receptor antagonism","volume":"39","author":"Beyer","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2020.01.015_bib60","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fnins.2018.00479","article-title":"Inhibition of diacylglycerol lipase impairs fear extinction in mice","volume":"12","author":"Cavener","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib61","doi-asserted-by":"crossref","first-page":"14782","DOI":"10.1038\/ncomms14782","article-title":"Endocannabinoid signalling modulates susceptibility to traumatic stress exposure","volume":"8","author":"Bluett","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2020.01.015_bib62","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/npp.2015.284","article-title":"Endocannabinoid modulation of predator stress-induced long-term anxiety in rats","volume":"41","author":"Lim","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib63","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.celrep.2016.06.082","article-title":"Endocannabinoid-mediated plasticity in nucleus accumbens controls vulnerability to anxiety after social defeat stress","volume":"16","author":"Bosch-Bouju","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.biopsych.2020.01.015_bib64","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1037\/adb0000154","article-title":"Prevalence and correlates of cannabis use in an outpatient VA posttraumatic stress disorder clinic","volume":"30","author":"Gentes","year":"2016","journal-title":"Psychol Addict Behav"},{"key":"10.1016\/j.biopsych.2020.01.015_bib65","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.biopsych.2011.04.022","article-title":"Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses","volume":"70","author":"Busquets-Garcia","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pbb.2010.12.002","article-title":"Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay","volume":"98","author":"Kinsey","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2020.01.015_bib67","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.phrs.2011.04.010","article-title":"Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats","volume":"64","author":"Sciolino","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.biopsych.2020.01.015_bib68","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/FBP.0b013e3283564dfa","article-title":"The temporal dynamics of the effects of monoacylglycerol lipase blockade on locomotion, anxiety, and body temperature","volume":"23","author":"Aliczki","year":"2012","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib69","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.yhbeh.2013.03.017","article-title":"Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice","volume":"63","author":"Aliczki","year":"2013","journal-title":"Horm Behav"},{"key":"10.1016\/j.biopsych.2020.01.015_bib70","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hipo.22344","article-title":"Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity","volume":"25","author":"Zhang","year":"2015","journal-title":"Hippocampus"},{"key":"10.1016\/j.biopsych.2020.01.015_bib71","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/mp.2016.22","article-title":"Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses","volume":"22","author":"Wang","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib72","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/npp.2016.3","article-title":"Ketamine and MAG lipase inhibitor-dependent reversal of evolving depressive-like behavior during forced abstinence from alcohol drinking","volume":"41","author":"Holleran","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib73","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/s41386-018-0055-3","article-title":"Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake","volume":"43","author":"Serrano","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib74","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1089\/neu.2018.5854","article-title":"A\u00a0novel role for the endocannabinoid system in ameliorating motivation for alcohol drinking and negative behavioral affect after traumatic brain injury in rats","volume":"36","author":"Fucich","year":"2019","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.biopsych.2020.01.015_bib75","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuropharm.2016.08.020","article-title":"Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety","volume":"111","author":"Morena","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib76","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1038\/npp.2011.166","article-title":"Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: A potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation","volume":"36","author":"Sumislawski","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib77","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.phrs.2017.02.022","article-title":"The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors","volume":"119","author":"Bakas","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.biopsych.2020.01.015_bib78","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.neuron.2017.02.025","article-title":"Cell-autonomous excitation of midbrain dopamine neurons by endocannabinoid-dependent lipid signaling","volume":"93","author":"Gantz","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2020.01.015_bib79","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","article-title":"Regional alterations in the endocannabinoid system in an animal model of depression: Effects of concurrent antidepressant treatment","volume":"106","author":"Hill","year":"2008","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2020.01.015_bib80","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1523\/JNEUROSCI.5346-07.2008","article-title":"Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum","volume":"28","author":"Rossi","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib81","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/mol.110.064196","article-title":"Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition","volume":"78","author":"Rossi","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib82","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/npp.2010.99","article-title":"Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress","volume":"35","author":"Wang","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib83","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbr.2009.05.013","article-title":"Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats","volume":"203","author":"Reich","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2020.01.015_bib84","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2012.11.017","article-title":"Age of stress exposure modulates the immediate and sustained effects of repeated stress on corticolimbic cannabinoid CB(1) receptor binding in male rats","volume":"249","author":"Lee","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2020.01.015_bib85","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1523\/JNEUROSCI.0163-14.2014","article-title":"Experience salience gates endocannabinoid signaling at hypothalamic synapses","volume":"34","author":"Wamsteeker Cusulin","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib86","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1038\/npp.2009.101","article-title":"Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala","volume":"34","author":"Patel","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib87","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuroscience.2011.08.048","article-title":"Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice","volume":"204","author":"Bowles","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2020.01.015_bib88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellsig.2017.01.024","article-title":"GPCR desensitization: Acute and prolonged phases","volume":"41","author":"Rajagopal","year":"2018","journal-title":"Cell Signal"},{"key":"10.1016\/j.biopsych.2020.01.015_bib89","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3940(93)90437-P","article-title":"Glucocorticoid regulation of cannabinoid receptor messenger RNA levels in the rat caudate-putamen. An in situ hybridization study","volume":"156","author":"Mailleux","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2020.01.015_bib91","first-page":"60","article-title":"Rapid changes in cannabinoid 1 receptor availability in cannabis-dependent male subjects after abstinence from cannabis","volume":"1","author":"D\u2019Souza","year":"2016","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.1016\/j.biopsych.2020.01.015_bib92","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/adb.12116","article-title":"[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users","volume":"20","author":"Ceccarini","year":"2015","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib93","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib94","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neuroimage.2018.10.013","article-title":"Sex difference in brain CB1 receptor availability in man","volume":"184","author":"Laurikainen","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2020.01.015_bib95","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/mp.2013.61","article-title":"Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study","volume":"18","author":"Neumeister","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib96","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41401-018-0081-z","article-title":"Endocannabinoid signaling in psychiatric disorders: A review of positron emission tomography studies","volume":"40","author":"Sloan","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.biopsych.2020.01.015_bib97","doi-asserted-by":"crossref","first-page":"pyv091","DOI":"10.1093\/ijnp\/pyv091","article-title":"Impaired 2-AG signaling in hippocampal glutamatergic neurons: Aggravation of anxiety-like behavior and unaltered seizure susceptibility","volume":"19","author":"Guggenhuber","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib98","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.psyneuen.2009.03.013","article-title":"Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress","volume":"34","author":"Hill","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib99","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.psyneuen.2013.08.004","article-title":"Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks","volume":"38","author":"Hill","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062741","article-title":"Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder","volume":"8","author":"Hauer","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.biopsych.2020.01.015_bib101","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1515\/revneuro-2012-0058","article-title":"Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: relationship to early cognitive dysfunction and late depression","volume":"23","author":"Hauer","year":"2012","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.biopsych.2020.01.015_bib102","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pnpbp.2016.01.004","article-title":"Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors","volume":"67","author":"Yi","year":"2016","journal-title":"Prog Neuropsychopharmacology Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib103","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/13543776.2018.1389899","article-title":"A\u00a0patent review of monoacylglycerol lipase (MAGL) inhibitors (2013-2017)","volume":"27","author":"Granchi","year":"2017","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.biopsych.2020.01.015_bib104","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"Hohmann","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2020.01.015_bib105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbalip.2008.10.007","article-title":"Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in\u00a0vivo","volume":"1791","author":"Bisogno","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biopsych.2020.01.015_bib106","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.chembiol.2009.09.012","article-title":"Discovery of potent and reversible monoacylglycerol lipase inhibitors","volume":"16","author":"King","year":"2009","journal-title":"Chem Biol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib108","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2018.07.036","article-title":"Monoacylglycerol lipase (MAGL) as a promising therapeutic target","volume":"157","author":"Gil-Ordonez","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib109","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1124\/jpet.118.252296","article-title":"Monoacylglycerol lipase inhibition in human and rodent systems supports clinical evaluation of endocannabinoid modulators","volume":"367","author":"Clapper","year":"2018","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2020.01.015_bib110","author":"Pilon"},{"key":"10.1016\/j.biopsych.2020.01.015_bib111","doi-asserted-by":"crossref","first-page":"9205","DOI":"10.1021\/acs.jmedchem.8b00824","article-title":"Design, synthesis, and evaluation of piperazinyl pyrrolidin-2-ones as a novel series of reversible monoacylglycerol lipase inhibitors","volume":"61","author":"Aida","year":"2018","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2020.01.015_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152473","article-title":"Endocannabinoid signaling regulates sleep stability","volume":"11","author":"Pava","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.biopsych.2020.01.015_bib113","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/jpet.115.222836","article-title":"Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Delta9-tetrahydrocannabinol in mice","volume":"353","author":"Hruba","year":"2015","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2020.01.015_bib114","doi-asserted-by":"crossref","first-page":"20270","DOI":"10.1073\/pnas.0909411106","article-title":"Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in\u00a0vivo","volume":"106","author":"Long","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2020.01.015_bib115","doi-asserted-by":"crossref","first-page":"e749","DOI":"10.1038\/tp.2016.26","article-title":"2-Arachidonoylglycerol signaling impairs short-term fear extinction","volume":"6","author":"Hartley","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib116","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00213-015-3917-y","article-title":"2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons","volume":"232","author":"Llorente-Berzal","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib117","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib118","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fpsyt.2014.00118","article-title":"Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues","volume":"5","author":"Wenzel","year":"2014","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib119","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuropharm.2017.06.032","article-title":"Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice","volume":"125","author":"Owens","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib120","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/0269881116645269","article-title":"True alignment of preclinical and clinical research to enhance success in CNS drug development: A review of the current evidence","volume":"30","author":"Goetghebeur","year":"2016","journal-title":"J\u00a0Psychopharmacol (Oxf)"},{"key":"10.1016\/j.biopsych.2020.01.015_bib121","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.semnuclmed.2016.09.001","article-title":"Imaging in central nervous system drug discovery","volume":"47","author":"Gunn","year":"2017","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.biopsych.2020.01.015_bib122","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/acs.jmedchem.8b01576","article-title":"Design, synthesis, and evaluation of (4 R)-1-{3-[2-((18)F)Fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbo nyl)piperazin-1-yl]pyrrolidin-2-one ([(18)F]T-401) as a novel positron-emission tomography imaging agent for monoacylglycerol lipase","volume":"62","author":"Hattori","year":"2019","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2020.01.015_bib123","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1021\/acs.jmedchem.8b01778","article-title":"Design, synthesis, and evaluation of reversible and irreversible monoacylglycerol lipase positron emission tomography (PET) tracers using a \u201ctail switching\u201d strategy on a piperazinyl azetidine skeleton","volume":"62","author":"Chen","year":"2019","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2020.01.015_bib124","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1021\/acs.jmedchem.7b01400","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of (11)C-labeled azetidinecarboxylates for imaging monoacylglycerol lipase by PET imaging studies","volume":"61","author":"Cheng","year":"2018","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2020.01.015_bib125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejmech.2017.04.066","article-title":"Synthesis and preclinical evaluation of [(11)C]MA-PB-1 for in\u00a0vivo imaging of brain monoacylglycerol lipase (MAGL)","volume":"136","author":"Ahamed","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.biopsych.2020.01.015_bib126","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.7150\/thno.15257","article-title":"Synthesis and preclinical evaluation of sulfonamido-based [(11)C-carbonyl]-carbamates and ureas for imaging monoacylglycerol lipase","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.biopsych.2020.01.015_bib127","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2008.10.047","article-title":"Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function","volume":"66","author":"Hariri","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib128","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41386-019-0416-6","article-title":"Influence of Delta9-tetrahydrocannabinol on long-term neural correlates of threat extinction memory retention in humans","volume":"44","author":"Hammoud","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib129","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/mp.2012.72","article-title":"Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity","volume":"18","author":"Gunduz-Cinar","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib130","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1111\/bph.13560","article-title":"Involvement of endocannabinoid neurotransmission in the bed nucleus of stria terminalis in cardiovascular responses to acute restraint stress in rats","volume":"173","author":"Gomes-de-Souza","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2020.01.015_bib131","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/npp.2017.305","article-title":"Enhancing endocannabinoid neurotransmission augments the efficacy of extinction training and ameliorates traumatic stress-induced behavioral alterations in rats","volume":"43","author":"Morena","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2020.01.015_bib132","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pnpbp.2018.11.007","article-title":"Endocannabinoid interactions in the regulation of acquisition of contextual conditioned fear","volume":"90","author":"Balogh","year":"2019","journal-title":"Prog Neuropsychopharmacology Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.01.015_bib133","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2017.12.038","article-title":"Monoacylglycerol lipase inhibition alters social behavior in male and female rats after post-weaning social isolation","volume":"341","author":"Fontenot","year":"2018","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2020.01.015_bib134","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s00213-014-3846-1","article-title":"Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice","volume":"232","author":"Aliczki","year":"2015","journal-title":"Psychopharmacology"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322320300494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322320300494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:59:54Z","timestamp":1778637594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322320300494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":134,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0006322320300494"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.01.015","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}